Agomelatine in the treatment of major depressive disorder / Stephen M. Stahl en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 5 (Mayo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 5 (Mayo) . - pp. 616-626 Título : Agomelatine in the treatment of major depressive disorder : an 8-week, multicenter, randomized, placebo controlled trial Tipo de documento: texto impreso Autores: Stephen M. Stahl, Autor ; Maurizio Fava, Autor ; Madhukar H. Trivedi, Autor Fecha de publicación: 2022 Artículo en la página: pp. 616-626 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Acetamidas, Antidepresivos, Ansiedad, Trastorno depresivo mayor, Calidad de vida. Resumen: To evaluate the efficacy, safety, and tolerability of fixed-dose agomelatine 25 and 50 mg/d in the treatment of outpatients with moderate-to-severe major depressive disorder (MDD) compared to placebo. Link: ./index.php?lvl=notice_display&id=28192 [artículo] Agomelatine in the treatment of major depressive disorder : an 8-week, multicenter, randomized, placebo controlled trial [texto impreso] / Stephen M. Stahl, Autor ; Maurizio Fava, Autor ; Madhukar H. Trivedi, Autor . - 2022 . - pp. 616-626. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 5 (Mayo) . - pp. 616-626 Palabras clave: Acetamidas, Antidepresivos, Ansiedad, Trastorno depresivo mayor, Calidad de vida. Resumen: To evaluate the efficacy, safety, and tolerability of fixed-dose agomelatine 25 and 50 mg/d in the treatment of outpatients with moderate-to-severe major depressive disorder (MDD) compared to placebo. Link: ./index.php?lvl=notice_display&id=28192

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR∗D) study / Maurizio Fava en Psychiatric Clinics of North America, Año 2003 - Vol. 26 No. 2 (Junio)

Público ISBD [artículo]  inPsychiatric Clinics of North America > Año 2003 - Vol. 26 No. 2 (Junio) . - pp. 457-494 Título : Background and rationale for the sequenced treatment alternatives to relieve depression (STAR∗D) study Tipo de documento: texto impreso Autores: Maurizio Fava, Autor ; A. John Rush, Autor ; Madhukar H. Trivedi, Autor Fecha de publicación: 2020 Artículo en la página: pp. 457-494 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Protocolos clínicos, Ensayos clínicos, Terapia de modalidad combinada, Análisis costo-beneficio, Trastorno depresivo mayor, Escalas de calificación del estado psiquiátrico, Calidad de vida. Resumen: Sequenced Treatment Alternatives to Relieve Depression (STAR*D) attempts to fill in major clinical information gaps and to evaluate the theoretical principles and clinical beliefs that currently guide pharmacotherapy of major depressive disorder. The study is conducted in representative participant groups and settings using clinical management tools that easily can be applied in daily practice. Link: ./index.php?lvl=notice_display&id=24816 [artículo] Background and rationale for the sequenced treatment alternatives to relieve depression (STAR∗D) study [texto impreso] / Maurizio Fava, Autor ; A. John Rush, Autor ; Madhukar H. Trivedi, Autor . - 2020 . - pp. 457-494. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Psychiatric Clinics of North America > Año 2003 - Vol. 26 No. 2 (Junio) . - pp. 457-494 Palabras clave: Antidepresivos, Protocolos clínicos, Ensayos clínicos, Terapia de modalidad combinada, Análisis costo-beneficio, Trastorno depresivo mayor, Escalas de calificación del estado psiquiátrico, Calidad de vida. Resumen: Sequenced Treatment Alternatives to Relieve Depression (STAR*D) attempts to fill in major clinical information gaps and to evaluate the theoretical principles and clinical beliefs that currently guide pharmacotherapy of major depressive disorder. The study is conducted in representative participant groups and settings using clinical management tools that easily can be applied in daily practice. Link: ./index.php?lvl=notice_display&id=24816

Concise associated symptoms tracking scale / Madhukar H. Trivedi en The Journal of Clinical Psychiatry, Año 2011 - Vol.72 - No. 6 (Junio)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 6 (Junio) . - pp. 765-774. Título : Concise associated symptoms tracking scale : a brief self report and clinician rating of symptoms associated with suicidality Tipo de documento: texto impreso Autores: Madhukar H. Trivedi, Autor ; Stephen R. Wisniewski, Autor ; David W. Morris, Autor Fecha de publicación: 2022 Artículo en la página: pp. 765-774. Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Autoinforme, Inhibidores de la captación de serotonina, Ideación suicida, Suicidio. Resumen: US Food and Drug Administration (FDA) warnings recommend monitoring negative symptoms associated with the initiation of antidepressant medications as these symptoms may interfere with full recovery and pose safety concerns. There is currently no brief, reliable rating instrument for assessing treatment-emergent, negative symptoms. Link: ./index.php?lvl=notice_display&id=28007 [artículo] Concise associated symptoms tracking scale : a brief self report and clinician rating of symptoms associated with suicidality [texto impreso] / Madhukar H. Trivedi, Autor ; Stephen R. Wisniewski, Autor ; David W. Morris, Autor . - 2022 . - pp. 765-774. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 6 (Junio) . - pp. 765-774. Palabras clave: Trastorno depresivo mayor, Autoinforme, Inhibidores de la captación de serotonina, Ideación suicida, Suicidio. Resumen: US Food and Drug Administration (FDA) warnings recommend monitoring negative symptoms associated with the initiation of antidepressant medications as these symptoms may interfere with full recovery and pose safety concerns. There is currently no brief, reliable rating instrument for assessing treatment-emergent, negative symptoms. Link: ./index.php?lvl=notice_display&id=28007

Concise Health Risk Tracking scale / Madhukar H. Trivedi en The Journal of Clinical Psychiatry, Año 2011 - Vol.72 - No. 6 (Junio)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 6 (Junio) . - pp. 757-764 Título : Concise Health Risk Tracking scale : a brief self report and clinician rating of suicidal risk Tipo de documento: texto impreso Autores: Madhukar H. Trivedi, Autor ; Stephen R. Wisniewski, Autor ; David W. Morris, Autor Fecha de publicación: 2022 Artículo en la página: pp. 757-764 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Psicometría, Inhibidores de la captación de serotonina, Ideación suicida, Suicidio. Resumen: Monitoring suicidality and risk following initiation of antidepressant treatment is an essential component of clinical care, but few brief, reliable ratings of suicidal ideation and behavior in adults are available. This report evaluates the psychometric properties of a brief self- and clinician-rated measure of factors related to the risk of suicide attempt or completion. Link: ./index.php?lvl=notice_display&id=28006 [artículo] Concise Health Risk Tracking scale : a brief self report and clinician rating of suicidal risk [texto impreso] / Madhukar H. Trivedi, Autor ; Stephen R. Wisniewski, Autor ; David W. Morris, Autor . - 2022 . - pp. 757-764. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 6 (Junio) . - pp. 757-764 Palabras clave: Trastorno depresivo mayor, Psicometría, Inhibidores de la captación de serotonina, Ideación suicida, Suicidio. Resumen: Monitoring suicidality and risk following initiation of antidepressant treatment is an essential component of clinical care, but few brief, reliable ratings of suicidal ideation and behavior in adults are available. This report evaluates the psychometric properties of a brief self- and clinician-rated measure of factors related to the risk of suicide attempt or completion. Link: ./index.php?lvl=notice_display&id=28006

Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder / Madhukar H. Trivedi en Journal of Clinical Psychopharmacology, Año 2004 - Vol. 24 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 5 (Octubre) . - pp. 497-506 Título : Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder Tipo de documento: texto impreso Autores: Madhukar H. Trivedi, Autor ; George J. Wan, Autor ; Rajiv Mallick, Autor Fecha de publicación: 2023 Artículo en la página: pp. 497-506 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Enfermedad aguda, Atención Ambulatoria, Ciclohexanoles, Trastorno depresivo mayor, Costos de medicamentos, Fluoxetina, Fluvoxamina, Paroxetina, Años de vida ajustados por calidad, Inhibidores selectivos de la recaptación de serotonina. Resumen: The purpose of this retrospective analysis was to estimate the cost and effectiveness of venlafaxine extended-release (VXR) compared with selective serotonin reuptake inhibitors in the outpatient treatment of major depressive disorder. Link: ./index.php?lvl=notice_display&id=30943 [artículo] Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder [texto impreso] / Madhukar H. Trivedi, Autor ; George J. Wan, Autor ; Rajiv Mallick, Autor . - 2023 . - pp. 497-506. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2004 - Vol. 24 - No. 5 (Octubre) . - pp. 497-506 Palabras clave: Enfermedad aguda, Atención Ambulatoria, Ciclohexanoles, Trastorno depresivo mayor, Costos de medicamentos, Fluoxetina, Fluvoxamina, Paroxetina, Años de vida ajustados por calidad, Inhibidores selectivos de la recaptación de serotonina. Resumen: The purpose of this retrospective analysis was to estimate the cost and effectiveness of venlafaxine extended-release (VXR) compared with selective serotonin reuptake inhibitors in the outpatient treatment of major depressive disorder. Link: ./index.php?lvl=notice_display&id=30943

Early adverse events and attrition in selective serotonin reuptake inhibitor treatment / Diane Warden en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)

Permalink

Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression / Vanina Popova en The American Journal of Psychiatry, Año 2019 - Vol. 176 - No. 6 (Junio)

Permalink

Exercise as an augmentation treatment for nonremitted major depressive disorder / Madhukar H. Trivedi en The Journal of Clinical Psychiatry, Año 2011 - Vol.72 - No. 5 (Mayo)

Permalink

Olanzapine/fluoxetine combination in patients with treatment-resistant depression / Mauricio Tohen en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 4 (Abril)

Permalink

Prevalence and impact of obsessive-compulsive symptoms in depression / Lee Baer en The Journal of Clinical Psychiatry, Año 2015 - Vol.76 - No.12 (Diciembre)

Permalink

Randomized Controlled Trial Comparing Exercise to Health Education for Stimulant Use Disorder / Madhukar H. Trivedi en The Journal of Clinical Psychiatry, Año 2017 - Vol. 78 No.8 ([18/12/2017])

Permalink

A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram / Madhukar H. Trivedi en The Journal of Clinical Psychiatry, Año 2013 - Vol.74 - No.8 (Agosto)

Permalink

A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram / Madhukar H. Trivedi en The Journal of Clinical Psychiatry, Año 2013 - Vol.74 - No.8 (Agosto)

Permalink

The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study / Ella J. Daly en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 1 (Febrero)

Permalink

Tiagabine in adult patients with generalized anxiety disorder / Mark H. Pollack en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)

Permalink

---

1 2 (1 - 15 / 16) Par page : Tout afficher